Judge Rules Pepcid Complete Patent Is Invalid
In a ruling Tuesday in the U.S. District Court for the Southern District of New York, Judge William H. Pauley III declared that the companies' patent for famotidine was invalid due to obviousness.
Perrigo said Wednesday that it would start marketing the drug under store brand and value brand labels following...
Already a subscriber? Click here to login